Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions
Trial ID or NCT#
NCT01908166
Status
NOT RECRUITING
Purpose
This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive way to check for kidney or liver solid focal lesions.
Official Title
US Elastography for Characterizing Focal Lesions in the Liver and Kidney
Eligibility Criteria
Ages Eligible for Study: Older than 19 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - There are no restrictions on life expectancy - Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed - Patients of any ethnic background - Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
- - Patients should not be taking other investigational agents - No requirements due to co-morbid disease or intercurrent illness, as needed - No restrictions on allergic reactions as no imaging agent will be used - Concomitant medications for treatment of the target lesion - Pregnant or nursing patients will be excluded from the study
Investigator(s)
Eila C. Skinner
Urologic oncologist,
Urologist,
Urologic surgeon
Thomas A. Stamey Research Professor of Urology
Benjamin I. Chung
Urologic oncologist,
Urologic specialist,
Urologist,
Genitourinary specialist,
Urologic surgeon
Associate Professor of Urology
Harcharan Gill
Urologic oncologist,
Urologist,
Genitourinary specialist,
Urologic surgeon
Kathryn Simmons Stamey Professor, Emeritus
Contact us to find out if this trial is right for you.
Contact
CCT
650-498-7061
View on ClinicalTrials.gov
